Previous Article in Journal
Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study
 
 
Review

Article Versions Notes

Curr. Oncol. 2026, 33(2), 82; https://doi.org/10.3390/curroncol33020082
Action Date Notes Link
article html file updated 30 January 2026 13:41 CET Original file https://www.mdpi.com/1718-7729/33/2/82/html
article pdf uploaded. 30 January 2026 13:39 CET Version of Record https://www.mdpi.com/1718-7729/33/2/82/pdf
article xml uploaded. 30 January 2026 13:39 CET Update https://www.mdpi.com/1718-7729/33/2/82/xml
article xml file uploaded 30 January 2026 13:39 CET Original file -
Back to TopTop